Gainers

• Tivic Health Systems (NASDAQ:TIVC) shares increased by 75.3% to $0.46 during Friday's pre-market session. The company's market cap stands at $2.8 million.
• Doximity (NYSE:DOCS) stock rose 29.94% to $56.42. The company's market cap stands at $10.4 billion. As per the press release, Q2 earnings came out yesterday.
• Fortrea Holdings (NASDAQ:FTRE) stock rose 26.31% to $22.8. The market value of their outstanding shares is at $2.0 billion. As per the news, the Q3 earnings report came out today.
• Tenaya Therapeutics (NASDAQ:TNYA) shares moved upwards by 20.39% to $3.01. The company's market cap stands at $237.4 million. The company's, Q3 earnings came out 2 days ago.
• Indaptus Therapeutics (NASDAQ:INDP) stock rose 15.11% to $1.37. The company's market cap stands at $13.9 million.
• CytomX Therapeutics (NASDAQ:CTMX) shares rose 14.99% to $1.15. The company's market cap stands at $89.8 million. As per the news, the Q3 earnings report came out yesterday.

Losers

• ProPhase Labs (NASDAQ:PRPH) stock declined by 51.8% to $0.69 during Friday's pre-market session. The company's market cap stands at $13.1 million.
• Maravai LifeSciences (NASDAQ:MRVI) stock decreased by 40.06% to $4.7. The market value of their outstanding shares is at $665.3 million. As per the news, the Q3 earnings report came out yesterday.
• Evolent Health (NYSE:EVH) stock decreased by 38.75% to $15.05. The market value of their outstanding shares is at $1.7 billion. As per the press release, Q3 earnings came out yesterday.
• Agilon Health (NYSE:AGL) stock fell 33.34% to $1.86. The market value of their outstanding shares is at $765.3 million. As per the news, the Q3 earnings report came out yesterday.
• AlloVir (NASDAQ:ALVR) shares declined by 29.7% to $0.69. The market value of their outstanding shares is at $79.6 million.
• Revance Therapeutics (NASDAQ:RVNC) shares decreased by 25.61% to $4.3. The company's market cap stands at $447.9 million. The company's, Q3 earnings came out yesterday.

This article was generated by Benzinga's automated content engine and reviewed by an editor.